جست‌وجوی استاد و پژوهشگر

Kirsten Wiese Simonsenمشاهده پروفایل

پژوهشگر

• Forensic Chemistry
• Toxicology
• Drug-related Deaths
• +۳ مورد دیگر

Kirsten Wiese Simonsen is a Forensic Chemist and PhD at the Section of Forensic Chemistry within the Faculty of Health and Medical Sciences at the University of Copenhagen. With a Cand. Pharm. degree from 1984 and a PhD in clinical and analytical chemistry from 1988, she has extensive experience in forensic toxicology and drug-related research. Her career path includes positions at: Retskemisk Institut, Copenhagen (1 year) Retsmedicinsk Institut, Odense University (1989-1997) Retskemisk Afdeling, Aarhus University (1997-2001) Retskemisk Afdeling, University of Copenhagen (2001-present) Dr. Simonsen specializes in forensic chemistry with research interests focused on method development, street-level drug analysis, drug-related deaths, and the relationship between drugs and traffic safety. Her work has significant implications for public health policy and forensic science practices. Her research demonstrates consistent focus on drug-related mortality patterns across Nordic countries, impaired driving due to substances, and forensic toxicology methodology. She has led significant projects including the Nordic collaboration on drug-related deaths (which she has coordinated since 2007) and the Gadeplansprojektet (which she has led since 2000). Dr. Simonsen has contributed to important European research initiatives, most notably the DRUID project (2006-2011) which aimed to establish harmonized EU regulations for combating driving under the influence of alcohol, medicines, and drugs. Her scientific contributions have been recognized through: 54 research outputs including journal articles, reports, and conference presentations Collaboration in Nordic and European research networks Policy impact with references in policy sources Media attention with coverage in news outlets and social media Dr. Simonsen has served on various committees related to drugs and drug-related deaths, including committees under the Ministry of Justice (1989-1997), and various committees of the Danish Health Authority and Police. She has been involved in establishing projects like Gadeplansprojektet and Extasyprojektet. Her laboratory work focuses on forensic chemical analysis, particularly in the areas of drug testing, toxicology, and method validation for detecting substances in biological samples.

Sandra Søgaard Tøttenborgمشاهده پروفایل

دانشیار

• Environmental Health
• Occupational Health
• Fetal Development
• +۴ مورد دیگر

Sandra Søgaard Tøttenborg serves as Associate Professor in the Section of Environmental Health within the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences. She concurrently holds the position of Head of Environmental Research at Copenhagen University Hospital - Bispebjerg and Frederiksberg since November 2016, maintaining dual academic-clinical appointments. Her ORCID profile (0000-0001-7742-4360) and institutional contact details reflect active scholarly engagement across both institutions. Her research focuses on environmental and occupational impacts on human health, with particular emphasis on fetal programming through chemical exposures during vulnerable developmental windows. She specializes in register-based epidemiology, longitudinal data analysis, and advanced statistical modeling of chemical mixtures. Current leadership roles include three major projects: the EXCOVER partnership on occupational exposures, the FEPOS cohort investigating fetal programming of semen quality, and the HESPAIR cohorts examining indoor air PCB effects. Her methodological expertise spans complex mixture analysis and large-scale registry utilization. Analysis of her 2025 publications reveals a cohesive research trajectory centered on reproductive and developmental epidemiology, with dominant themes including endocrine disruptors, chemical mixture effects, paternal exposures, and sex-specific health outcomes. Key methodological approaches involve Danish national birth cohorts and register-based designs, consistently addressing environmental health questions through longitudinal frameworks that bridge fetal exposures to adult disease manifestations. While no specific scientific awards are documented in the source material, her leadership of multiple large-scale cohort studies indicates substantial research funding and institutional recognition. Her externally funded projects demonstrate capacity to secure competitive grants for complex environmental health investigations. Dr. Tøttenborg currently directs three major externally funded initiatives: EXCOVER (Occupational and Environmental Exposures partnership), FEPOS (Fetal Programming of Semen Quality cohort), and HESPAIR (Health Effects of PCBs in indoor Air cohorts). These projects involve interdisciplinary collaborations across epidemiology, toxicology, and clinical medicine, leveraging Denmark's comprehensive health registries. Although specific advisees aren't listed, her section leadership role implies supervision of junior researchers and graduate students. As Head of Research at Bispebjerg and Frederiksberg Hospital's Department of Occupational and Environmental Health, she directs the HESPAIR cohort studies on indoor air pollutants. Her team maintains active collaborations within the University of Copenhagen's Faculty of Health and Medical Sciences, focusing on translating environmental exposure data into public health interventions through rigorous epidemiological methods and policy-relevant research outputs.

• Population Genetics
• Evolutionary Biology
• Statistical Genetics
• +۴ مورد دیگر

Jonas Meisner serves as an Assistant Professor in the Rasmussen Group at the Faculty of Health and Medical Sciences, University of Copenhagen. His research program bridges population genetics, evolutionary biology, and statistical methodology development, with significant contributions to understanding genetic variation in both human and wildlife populations. Meisner's research interests center on population structure analysis , ancestry estimation methods , polygenic prediction techniques , and evolutionary history reconstruction . His work applies sophisticated statistical approaches to genomic datasets from diverse populations including Greenlandic Inuit communities and wildlife species such as giraffes and wildebeest. This research has important implications for understanding human adaptation, disease susceptibility patterns, and conservation strategies for endangered species. His publication record demonstrates a clear trajectory toward interdisciplinary research that integrates population genetics with evolutionary biology and medical genomics. Meisner frequently employs large-scale genomic analyses of both contemporary and ancient DNA samples, with particular emphasis on Arctic-adapted populations and wildlife conservation genetics. His methodological innovations in ancestry estimation and haplotype-based analysis have been featured in premier scientific journals including Nature, Cell, and Nature Genetics. Meisner is affiliated with the Rasmussen Group, a research team focused on advancing population genetics methodologies and applying them to significant biological and medical questions. The group's collaborative work spans human medical genetics, wildlife conservation genetics, and computational method development in statistical genetics.

Johanne Marie Justesenمشاهده پروفایل

استادیار

• Genetics
• Metabolic Diseases
• Diabetes Research
• +۵ مورد دیگر

Johanne Marie Justesen serves as an Assistant Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research is prominently featured in high-impact journals across multiple disciplines including genetics, metabolic diseases, and cardiovascular biology. Her research interests focus on the genetic underpinnings of metabolic disorders, particularly fatty liver disease, diabetes, and cardiovascular conditions. Dr. Justesen employs genomic and molecular approaches to investigate how genetic variants influence disease mechanisms and metabolic pathways. Her work bridges basic science with clinical applications, exploring how genetic risk factors interact with lifestyle elements like physical activity and diet. Analysis of Dr. Justesen's publication record reveals a strong focus on polygenic risk scores, gene variant effects on metabolic parameters, and the molecular mechanisms underlying metabolic dysfunction. Her research spans from basic genomic analysis to translational studies with potential clinical applications, particularly in diabetes and cardiovascular disease management. Dr. Justesen is affiliated with the Grarup Group at CBMR, which focuses on the genetic architecture of metabolic diseases. Her collaborative network includes researchers across multiple institutions, as evidenced by her extensive co-authorship on publications involving international teams. The significant media coverage of her work (picked up by over 40 news outlets for some publications) indicates the relevance and impact of her research in the scientific community.